A novel long non-coding RNA-KAT7 is low expressed in colorectal cancer and acts as a tumor suppressor

Qingmei Wang; Rongzhang He; Tan Tan; Jia Li; Zheng Hu; Weihao Luo; Lili Duan; Wenna Luo; Dixian Luo

doi:10.1186/s12935-019-0760-y

A novel long non-coding RNA-KAT7 is low expressed in colorectal cancer and acts as a tumor suppressor

Cancer Cell Int. 2019 Feb 26:19:40. doi: 10.1186/s12935-019-0760-y. eCollection 2019.

Authors

Qingmei Wang^#^{1

2}, Rongzhang He^#^{1

3}, Tan Tan^#^{1

2}, Jia Li¹, Zheng Hu¹, Weihao Luo¹, Lili Duan¹, Wenna Luo¹, Dixian Luo^{1

2}

Affiliations

¹ 1Translational Medicine Institute, National & Local Joint Engineering Laboratory for High-throughput Molecular Diagnosis Technology, The First People's Hospital of Chenzhou, University of South China, Chenzhou, 423000 People's Republic of China.
² 2Center for Clinical Pathology, The First People's Hospital of Chenzhou, University of South China, Chenzhou, 423000 People's Republic of China.
³ 3Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410078 People's Republic of China.

^# Contributed equally.

Abstract

Background: The abnormal expression of many long non-coding RNAs (lncRNAs) has been reported in the progression of various tumors. However, the potential biological roles and regulatory mechanisms of long non-coding RNAs in the development of colorectal cancer (CRC) have not yet been fully elucidated. Therefore, it is crucial to identify that lncRNAs can be used for the clinical prevention and treatment of CRC.

Methods: In our previous work, we identificated a novel lncRNA, lncRNA-KAT7, and found that the expression of lncRNA-KAT7 in CRC tissues was significantly lower than that in matched normal intestinal tissues, and the expression in CRC cell lines was lower than that of normal intestinal epithelial cells (P < 0.05). Besides, the expression of lncRNA-KAT7 is negative associated with age, tumor size, tumor differentiation, lymph node metastasis of CRC patients. The potential biological effects and molecular mechanisms of lncRNA-KAT7 in CRC were evaluated using a series of CCK-8 assay, clone formation assay, EdU proliferation assay, scratch determination, transwell determination, western blot analysis, and nude subcutaneous tumorigenesis model construction cell and animal experiments.

Results: The expression of lncRNA-KAT7 in CRC tissues was lower than that in matched normal tissues and normal intestinal epithelial cells (P < 0.05). Decreased expression of lncRNA-KAT7 is associated with clinicopathological features of poor CRC patients. In vitro experiments showed that up-regulation of lncRNA-KAT7 expression in CRC cells inhibited cell proliferation and migration. In vivo animal experiments showed that the lncRNA-KAT7 also inhibited tumor growth. Western blot analysis showed that the expression of lncRNA-KAT7 was up-regulated in HCT116 cells, the expression of E-cadherin increased, and the expression of Vimentin, MMP-2 and β-catenin protein was down-regulated so did the phosphorylation NF-κB P65. The results confirm that the expression of lncRAN-KAT7 can inhibit the malignant phenotype of CRC cells.

Conclusions: Up to now, as a novel lncRNA, lncRNA-KAT7 has not any relevant research and reports. The results confirm that the expression of lncRNA-KAT7 can inhibit the malignant phenotype of CRC cells. And it can be used as a new diagnostic biomarker and therapeutic target for the development of CRC.

Keywords: Colorectal cancer; Invasion; Migration; Proliferation; Tumor suppressor; lncRNA-KAT7.